跳至主要内容
临床试验/JPRN-UMIN000023663
JPRN-UMIN000023663已完成未知

Effect of ingestion of trial supplement on serum uric acid level -A double blind, placebo controlled study- - Effect of ingestion of trial supplement on serum uric acid level

FANCL Corporation0 个研究点目标入组 40 人开始时间: 2016年8月19日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 65years-old(—)
性别
Male

入选标准

  • 未提供

排除标准

  • 1) Subjects who are under treatment or have a history of hyperuricemia or gout. 2) Subjects who have a history of gouty arthritis or gouty arthritis. 3) Subjects who are under treatment or have a history of rheumatoid arthritis. 4) Subjects who have a history of urinary stone or kidney stone. 5) Subjects who has a disease under treatment or are judged to that medical treatment are necessary by the doctor 6) Subjects who have under treatment or history of disease such as diabetes, liver disease, kidney disease, heart disease, adrenal cortex disease. 7) Subjects who are routinely use the health food, dietary supplement, and medicine including over-the-counter drug for improving of serum uric acid. 8) Subjects who routinely use or are planned to use analgesics (non-steroidal analgesics, steroidal analgesics, etc.). 9) Subjects with allergies to the products used in the study. 10) Subjects who are planned to change their lifestyle. 11) Subjects who have participated in other clinical study within the last one month prior to the current study 12) Subjects who are judged as unsuitable for the study by the investigator for other reason

研究者

相似试验

Effect of ingestion of trial supplement on serum... | 临床试验